Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Short Interest Up 3,752.6% in February

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) saw a large growth in short interest in the month of February. As of February 27th, there was short interest totaling 3,660 shares, a growth of 3,752.6% from the February 12th total of 95 shares. Approximately 1.5% of the company’s stock are short sold. Based on an average daily volume of 3,171 shares, the short-interest ratio is currently 1.2 days. Based on an average daily volume of 3,171 shares, the short-interest ratio is currently 1.2 days. Approximately 1.5% of the company’s stock are short sold.

Bitwise MARA Option Income Strategy ETF Stock Performance

Shares of NYSEARCA IMRA traded down $0.02 during mid-day trading on Tuesday, reaching $13.75. The company had a trading volume of 12,037 shares, compared to its average volume of 6,073. The company has a market capitalization of $3.30 million, a price-to-earnings ratio of 275.00 and a beta of -6.67. The stock has a fifty day moving average of $15.05 and a two-hundred day moving average of $24.44. Bitwise MARA Option Income Strategy ETF has a 12-month low of $11.99 and a 12-month high of $60.73.

About Bitwise MARA Option Income Strategy ETF

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.